These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19540383)

  • 21. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients.
    Simon N; Finzi J; Cayla G; Montalescot G; Collet JP; Hulot JS
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1059-66. PubMed ID: 26071277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP-mediated pharmacologic interference with optimal platelet inhibition.
    Cuisset T; Quilici J
    J Cardiovasc Transl Res; 2013 Jun; 6(3):404-10. PubMed ID: 23314910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
    Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P
    Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.
    Siepmann T; Heinke D; Kepplinger J; Barlinn K; Gehrisch S; Grählert X; Schwanebeck U; Reichmann H; Puetz V; Bodechtel U; Gahn G
    Br J Clin Pharmacol; 2014 Nov; 78(5):1058-66. PubMed ID: 24803100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interaction: Clopidogrel and PPIs.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):39-40. PubMed ID: 28222065
    [No Abstract]   [Full Text] [Related]  

  • 28. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
    Tran M; Tafreshi J; Pai RG
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thienopyridine-associated drug-drug interactions: pharmacologic mechanisms and clinical relevance.
    Hulot JS; Collet JP; Montalescot G
    Curr Cardiol Rep; 2011 Oct; 13(5):451-8. PubMed ID: 21826477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
    Bretagne JF
    Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.
    Pinheiro LF; França CN; Izar MC; Barbosa SP; Bianco HT; Kasmas SH; Mendes GD; Povoa RM; Fonseca FA
    Int J Cardiol; 2012 Jun; 158(1):125-9. PubMed ID: 22569318
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of omeprazole on platelet inhibition of clopidogrel in various CYP2C19 mutant alleles.
    Liu Q; Dang DS; Chen YF; Yan M; Shi GB; Zhao QC
    Genet Test Mol Biomarkers; 2012 Nov; 16(11):1293-7. PubMed ID: 23046071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H; Lindhoff-Last E
    Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential Drug Interaction Between an Antiplatelet Agent and a Proton Pump Inhibitor.
    Nguyen T; Gavrilova R; Blazhko M
    Consult Pharm; 2016; 31(10):593-597. PubMed ID: 27725069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between statins and clopidogrel: is there anything clinically relevant?
    Bhindi R; Ormerod O; Newton J; Banning AP; Testa L
    QJM; 2008 Dec; 101(12):915-25. PubMed ID: 18676683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dilemma between gastroprotection and cardiovascular prevention].
    Venerito M; Kandulski A; Malfertheiner P
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2193-8. PubMed ID: 20979006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of statins on platelet inhibition by a high loading dose of clopidogrel.
    Müller I; Besta F; Schulz C; Li Z; Massberg S; Gawaz M
    Circulation; 2003 Nov; 108(18):2195-7. PubMed ID: 14568892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel-statin interaction: myth or reality?
    Angiolillo DJ; Alfonso F
    J Am Coll Cardiol; 2007 Jul; 50(4):296-8. PubMed ID: 17659195
    [No Abstract]   [Full Text] [Related]  

  • 39. Concurrent use of clopidogrel (Plavix) and atorvastatin (Lipitor) is contraindicated.
    Masunyane L
    S Afr Med J; 2006 Jun; 96(6):474-5. PubMed ID: 16862652
    [No Abstract]   [Full Text] [Related]  

  • 40. Do statins really interfere with clopidogrel-induced platelet function?
    Shechter M
    Eur Heart J; 2004 Mar; 25(5):448; author reply 448-9. PubMed ID: 15033262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.